Cargando…
Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types
BACKGROUND: CD276 (also known as B7-H3) is one of the most important immune checkpoints of the CD28 and B7 superfamily, and its abnormal expression is closely associated with various types of cancer. It has been shown that CD276 is able to inhibit the function of T cells, and that this gene may pote...
Autores principales: | Dai, Lirui, Guo, Xuyang, Xing, Zhe, Tao, Yiran, Liang, Wulong, Shi, Zimin, Hu, Weihua, Zhou, Shaolong, Wang, Xinjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885708/ https://www.ncbi.nlm.nih.gov/pubmed/36717836 http://dx.doi.org/10.1186/s12885-023-10575-1 |
Ejemplares similares
-
SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer
por: Dai, Lirui, et al.
Publicado: (2022) -
SOCS proteins and their roles in the development of glioblastoma
por: Dai, Lirui, et al.
Publicado: (2022) -
Cholesterol metabolism and its implication in glioblastoma therapy
por: Guo, Xuyang, et al.
Publicado: (2022) -
Systematic characterization and biological functions of non‐coding RNAs in glioblastoma
por: Dai, Lirui, et al.
Publicado: (2022) -
Identification and validation of SOCS1/2/3/4 as potential prognostic biomarkers and correlate with immune infiltration in glioblastoma
por: Dai, Lirui, et al.
Publicado: (2023)